Retrospective Study of Germ Cell Tumors of the Central Nervous System

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospectively analyzing the epidemiological and clinical characteristics, treatment, recurrence, prognosis and prognostic factors of the germ-cell tumors of central nervous system in a single center.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Genetic and Molecular Characterization of Nervous System Lesions

NCT06314607

Brain Tumor Brain Lesion (General)

RECRUITING

Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China

NCT05672043

Medulloblastoma Central Nervous System Tumor, Pediatric Ependymoma +3 more

RECRUITING

Surveillance of Association of Immune Status and Prognosis of CNS Germ Cell Tumor Survivors

NCT04909307

Intracranial Germ Cell Tumor Intracranial Germ Cell CNS Tumor, Childhood Surgery

UNKNOWN

Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors

NCT05982691

CNS Germinoma CNS Tumor Asian Consortium

RECRUITING

Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas

NCT04216537

Glioma Molecular Sequence Variation Genetic Change

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Clinical data of patients with germ-cell tumors of central nervous system who were treated in the Department of Neuro-oncology, Sanbo Brain Hospital Capital Medical University between January 2007 and December 2022 were retrospectively collected, and the epidemiological and clinical characteristics, treatment, recurrence, prognosis and prognostic factors of the disease were analyzed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Germ Cell Tumor of CNS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinically or pathologically diagnosed as germ cell tumor of the central nervous system.
* Have received antitumor therapy.
* Patients who were clinically diagnosed based on neuroimaging characteristics and response to radiotherapy or chemotherapy were allowed for enrollment.